Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jorgensen

Showing results (281-290 of 290) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 290 results.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009James R Johnson, Carl Urban, Scott J Weissman, et al.
The New England Journal of Medicine|January 16, 2009
Effect of pneumococcal conjugate vaccine on pneumococcal meningitisHeather E Hsu, Kathleen A Shutt, Matthew R Moore, et al.
Journal of the American Board of Family Medicine : JABFM|September 9, 2011
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) studyNicolas A Forcade, Michael L Parchman, James H Jorgensen, et al.
Lancet (London, England)|October 31, 2006
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control studyCynthia G Whitney, Tamar Pilishvili, Monica M Farley, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trialMichael W Ellis, Matthew E Griffith, David P Dooley, et al.
Journal of Pediatric Hematology/Oncology|July 1, 1997
Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study IIG M Woods, J H Jorgensen, M A Waclawiw, et al.
The New England Journal of Medicine|April 7, 2006
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniaeMoe H Kyaw, Ruth Lynfield, William Schaffner, et al.
The Lancet. Respiratory Medicine|March 19, 2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control studyMatthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
The Journal of Infectious Diseases|April 19, 2008
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005Matthew R Moore, Robert E Gertz, Robyn L Woodbury, et al.
The Lancet. Infectious Diseases|February 7, 2015
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillanceMatthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009James R Johnson, Carl Urban, Scott J Weissman, et al.
The New England Journal of Medicine|January 16, 2009
Effect of pneumococcal conjugate vaccine on pneumococcal meningitisHeather E Hsu, Kathleen A Shutt, Matthew R Moore, et al.
Journal of the American Board of Family Medicine : JABFM|September 9, 2011
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) studyNicolas A Forcade, Michael L Parchman, James H Jorgensen, et al.
Lancet (London, England)|October 31, 2006
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control studyCynthia G Whitney, Tamar Pilishvili, Monica M Farley, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trialMichael W Ellis, Matthew E Griffith, David P Dooley, et al.
Journal of Pediatric Hematology/Oncology|July 1, 1997
Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study IIG M Woods, J H Jorgensen, M A Waclawiw, et al.
The New England Journal of Medicine|April 7, 2006
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniaeMoe H Kyaw, Ruth Lynfield, William Schaffner, et al.
The Lancet. Respiratory Medicine|March 19, 2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control studyMatthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
The Journal of Infectious Diseases|April 19, 2008
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005Matthew R Moore, Robert E Gertz, Robyn L Woodbury, et al.
The Lancet. Infectious Diseases|February 7, 2015
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillanceMatthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
Pageof 29